Literature DB >> 26363376

Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications.

Sheng Feng1, Yu Zhao2, Ming Xian3, Qian Wang4.   

Abstract

By electrospinning of polycaprolactone (PCL) solutions containing N-(benzoylthio)benzamide (NSHD1), a H2S donor, fibrous scaffolds with hydrogen sulfide (H2S) releasing capability (H2S-fibers) are fabricated. The resultant microfibers are capable of releasing H2S upon immersion in aqueous solution containing biological thiols under physiological conditions. The H2S release peaks of H2S-fibers appeared at 2-4h, while the peak of donor alone showed at 45 min. H2S release half-lives of H2S-fibers were 10-20 times longer than that of donor alone. Furthermore, H2S-fibers can protect cells from H2O2 induced oxidative damage by significantly decreasing the production of intracellular reactive oxygen species (ROS). Finally, we investigated the H2S-fibers application as a wound dressing in vitro. Given that H2S has a broad range of physiological functions, H2S-fibers hold great potential for various biomedical applications. STATEMENT OF SIGNIFICANCE: Hydrogen sulfide, as a gaseous messenger, plays a crucial role in many physiological and pathological conditions. Recent studies about functions of H2S suggests H2S-based therapy could be promising therapeutic strategy for many diseases, such as cardiovascular disease, arthritis, and inflammatory bowel disease. Although many H2S donors have been developed and applied for biomedical studies, most of H2S donors have the shortage that the H2S release is either too fast or uncontrollable, which poorly mimic the biological generation of H2S. By simply combining electrospinning technique with our designed biological thiols activated H2S donor, NSHD1, we fabricated H2S releasing microfibers (H2S-fibers). This H2S-fibers significantly prolonged the releasing time compared to H2S donor alone. By adjusting the electrospinning parameters, tunable releasing profiles can be achieved. Moreover, the H2S fibers can protect cardiac myoblasts H9c2 and fibroblast NIH 3T3 from oxidative damage and support their proliferation as cellular scaffolds. To our knowledge, this is the first report of electrospun fibers with H2S releasing capacity. We anticipate this H2S-releasing scaffold will have great potential for biomedical applications.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Controlled release; Electrospinning; Hydrogen sulfide; Ischemia reperfusion injury; NSHD1

Mesh:

Substances:

Year:  2015        PMID: 26363376      PMCID: PMC4609630          DOI: 10.1016/j.actbio.2015.09.010

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  49 in total

1.  Enzymatic desulfuration of beta-mercaptopyruvate to pyruvate.

Authors:  A MEISTER; P E FRASER; S V TICE
Journal:  J Biol Chem       Date:  1954-02       Impact factor: 5.157

Review 2.  Engineering cell alignment in vitro.

Authors:  Yuhui Li; Guoyou Huang; Xiaohui Zhang; Lin Wang; Yanan Du; Tian Jian Lu; Feng Xu
Journal:  Biotechnol Adv       Date:  2013-11-22       Impact factor: 14.227

3.  Proliferation and skeletal myotube formation capability of C2C12 and H9c2 cells on isotropic and anisotropic electrospun nanofibrous PHB scaffolds.

Authors:  Leonardo Ricotti; Alessandro Polini; Giada G Genchi; Gianni Ciofani; Donata Iandolo; Helena Vazão; Virgilio Mattoli; Lino Ferreira; Arianna Menciassi; Dario Pisignano
Journal:  Biomed Mater       Date:  2012-04-05       Impact factor: 3.715

4.  Functionalizing electrospun fibers with biologically relevant macromolecules.

Authors:  Cheryl L Casper; Nori Yamaguchi; Kristi L Kiick; John F Rabolt
Journal:  Biomacromolecules       Date:  2005 Jul-Aug       Impact factor: 6.988

5.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine.

Authors:  V P Bindokas; J Jordán; C C Lee; R J Miller
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

6.  Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion.

Authors:  Wei-Hua Sun; Fang Liu; Ying Chen; Yi-Chun Zhu
Journal:  Biochem Biophys Res Commun       Date:  2012-04-07       Impact factor: 3.575

7.  Cysteine-activated hydrogen sulfide (H2S) donors.

Authors:  Yu Zhao; Hua Wang; Ming Xian
Journal:  J Am Chem Soc       Date:  2010-12-10       Impact factor: 15.419

Review 8.  The therapeutic potential of hydrogen sulfide: separating hype from hope.

Authors:  Kenneth R Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

9.  Nitric oxide-releasing silica nanoparticle-doped polyurethane electrospun fibers.

Authors:  Ahyeon Koh; Alexis W Carpenter; Danielle L Slomberg; Mark H Schoenfisch
Journal:  ACS Appl Mater Interfaces       Date:  2013-08-05       Impact factor: 9.229

10.  Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis.

Authors:  J Slezak; N Tribulova; J Pristacova; B Uhrik; T Thomas; N Khaper; N Kaul; P K Singal
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

View more
  18 in total

Review 1.  The Benefits of Macromolecular/Supramolecular Approaches in Hydrogen Sulfide Delivery: A Review of Polymeric and Self-Assembled Hydrogen Sulfide Donors.

Authors:  Kuljeet Kaur; Ryan J Carrazzone; John B Matson
Journal:  Antioxid Redox Signal       Date:  2020-01-10       Impact factor: 8.401

2.  Supramolecular nanostructures with tunable donor loading for controlled H2S release.

Authors:  Yin Wang; John B Matson
Journal:  ACS Appl Bio Mater       Date:  2019-10-16

Review 3.  A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications.

Authors:  Chadwick R Powell; Kearsley M Dillon; John B Matson
Journal:  Biochem Pharmacol       Date:  2017-11-23       Impact factor: 5.858

4.  Hydrogen sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments.

Authors:  Alban Longchamp; Kuljeet Kaur; Diane Macabrey; Celine Dubuis; Jean-Marc Corpataux; Sébastien Déglise; John B Matson; Florent Allagnat
Journal:  Acta Biomater       Date:  2019-07-26       Impact factor: 8.947

5.  Electrospun Scaffolds Functionalized with a Hydrogen Sulfide Donor Stimulate Angiogenesis.

Authors:  Tianyu Yao; Teun van Nunen; Rebeca Rivero; Chadwick Powell; Ryan Carrazzone; Lilian Kessels; Paul Andrew Wieringa; Shahzad Hafeez; Tim G A M Wolfs; Lorenzo Moroni; John B Matson; Matthew B Baker
Journal:  ACS Appl Mater Interfaces       Date:  2022-06-17       Impact factor: 10.383

6.  The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.

Authors:  Qian Ding; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

8.  Kinetic Insights into Hydrogen Sulfide Delivery from Caged-Carbonyl Sulfide Isomeric Donor Platforms.

Authors:  Yu Zhao; Hillary A Henthorn; Michael D Pluth
Journal:  J Am Chem Soc       Date:  2017-11-02       Impact factor: 15.419

Review 9.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 10.  Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders.

Authors:  Chun-Tao Yang; Li Chen; Shi Xu; Jacob J Day; Xiang Li; Ming Xian
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.